The intervention centers on VR-based meditation sessions designed to guide attention and calm physiological arousal. Unlike standard relaxation materials, VR attempts to reduce exposure to stressful cues by replacing the immediate environment with a controlled, calming experience. The researchers focused on both perceived stress and related outcomes that reflect how stress may accumulate during prolonged NICU stays.

To evaluate effectiveness, participants were recruited from NICU parent populations and the care teams supporting them. Outcomes were tracked using validated psychological measures commonly used in clinical research, capturing changes in stress intensity over the course of the intervention. For providers, the design specifically targeted stress and burnout indicators, acknowledging that caregiver well-being can influence continuity of care.

The study’s analytical approach emphasizes statistical comparisons between pre- and post-intervention assessments, seeking evidence that VR meditation meaningfully shifts stress trajectories. By incorporating provider outcomes, the work also explores whether the same tool can act on the mental burden of the people delivering NICU care, potentially offering a dual-benefit model.

In the findings, VR meditation showed promising signals of stress reduction among parents, suggesting that immersive guided practice may be a practical adjunct to existing NICU support. For staff, the results point toward benefits that could translate into less emotional exhaustion and improved resilience—key elements in mitigating burnout.

Importantly, the research situates VR not as a replacement for clinical mental health care, but as an accessible coping technology that can be deployed within a stressful environment. The NICU context is especially relevant because families often endure uncertainty, sleep disruption, and high emotional load.

From a technology standpoint, the trial highlights how VR can deliver standardized, repeatable sessions—reducing variation that may occur with purely verbal or text-based interventions. This standardization is crucial for clinical scalability.

Overall, the study frames VR meditation as a viral-science-news style innovation: a low-complexity, high-immersion wellness tool with measurable clinical endpoints. If validated in broader trials, it could become a new element in NICU support programs for both families and the professionals caring for them.

Subject of Research: Stress among NICU parents and provider burnout; virtual reality–based meditation
Article Title: Evaluation of virtual reality-based meditation as a tool to mitigate stress among parents and providers in the neonatal intensive care unit.
Article References: Morrison, T.M., Jacobson, J., Feldman, H.A. et al. Evaluation of virtual reality-based meditation as a tool to mitigate stress among parents and providers in the neonatal intensive care unit. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02800-z
Image Credits: AI Generated
DOI: 10.1038/s41372-026-02800-z
Keywords: virtual reality, meditation, NICU, parental stress, provider burnout

The work focuses on infants born at or before 28 weeks’ gestation, a group especially vulnerable to fragile brain vasculature. In this early window, even routine resuscitation and respiratory management can influence physiological stability. The team therefore examined whether procedural difficulty—reflected by repeated laryngoscopy—correlates with subsequent severe IVH.

Technically, laryngoscopy is used to visualize the airway and support endotracheal intubation when needed. Each additional attempt may prolong exposure to factors such as fluctuating oxygenation, changing carbon dioxide levels, and transient cardiovascular stress. These perturbations are thought to affect cerebral blood flow regulation, which is already immature in very preterm babies.

To evaluate the association, investigators analyzed clinical data from extreme preterm infants, comparing the frequency of laryngoscopic attempts with outcomes related to IVH severity. The primary endpoint was severe IVH, indicating bleeding patterns that are clinically critical and associated with higher morbidity.

The findings suggest that the number of LAs is not a neutral byproduct of care, but may function as a measurable marker of procedural strain and airway-related instability. While observational designs cannot prove causality on their own, the strength and direction of the association raise important questions about how to optimize intubation strategies during this high-risk phase.

The study’s implications extend beyond documentation: if repeated laryngoscopy increases risk, then interventions aimed at improving first-attempt success—such as enhanced training, decision support, equipment optimization, and refined airway algorithms—could potentially reduce severe brain bleeding.

For clinicians, the message is practical: minimizing attempts may matter as much as the decision to intubate, particularly in the most premature patients. The authors emphasize the need for further research to clarify mechanisms and to test whether targeted improvements in intubation workflows can prevent IVH.

Overall, the report adds a new procedural dimension to neonatal risk monitoring, aligning airway management closely with neuroprotective outcomes in the earliest moments of life.

Subject of Research: Association between laryngoscopic attempt number and severe intraventricular hemorrhage in extreme preterm infants.

Article Title: Association of number of laryngoscopic attempts during the transitional period and severe intraventricular hemorrhage in extreme preterm infants.

Article References: Bait Raidan, H., Mohsen, N., Elhanefy, T. et al. Association of number of laryngoscopic attempts during the transitional period and severe intraventricular hemorrhage in extreme preterm infants. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02811-w

DOI: https://doi.org/10.1038/s41372-026-02811-w

Image Credits: AI Generated

Keywords: Laryngoscopic attempts; laryngoscopy; intraventricular hemorrhage; severe IVH; extreme preterm infants; transitional period; neonatal intubation.

Using data tied to routine ASD screening, the team examined patterns of “abnormal screening” in children with a history of extreme prematurity. The analysis highlights that screening performance—and the likelihood of an atypical result—may reflect a combination of biological vulnerability and the structure of follow-up care.

While ASD screening tools are designed to detect early behavioral signs, the study underscores that outcomes can be influenced by factors such as the child’s early medical course. Extremely preterm infants often experience complications that may affect brain development, including altered white-matter maturation and changes in early sensory processing. These mechanisms can contribute to delays or atypical trajectories that screening instruments attempt to capture.

Beyond biology, the results point to the importance of healthcare delivery. Differences in how families access developmental services, timing of assessments, and continuity of developmental surveillance can shape whether early signals are documented during the window when screening is most informative.

The findings are timely as perinatal medicine increasingly emphasizes “follow-up as prevention,” where monitoring is intended to trigger earlier evaluation, therapy, and support. The study suggests that abnormal screening should prompt systematic clinical review rather than be treated as a standalone label.

Importantly, the research does not claim that prematurity alone determines ASD outcomes. Instead, it reframes screening as a risk-detection process embedded in complex life-course factors. For clinicians, this means interpreting abnormal screening through a developmental lens—integrating perinatal history, current behavior, and the context of caregiver and service engagement.

For families, the study reinforces that early findings are best viewed as actionable prompts. When screening flags potential concerns, timely diagnostic assessment and early intervention can alter developmental trajectories, improving opportunities during a period of heightened neuroplasticity.

Subject of Research: Autism spectrum disorder screening in extremely preterm children

Article Title: Factors associated with abnormal screening for autism spectrum disorder among Extremely Preterm Children

Article References: Peralta-Carcelen, M., Hintz, S.R., Bann, C.M. et al. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02693-y

Image Credits: AI Generated

DOI: 10.1038/s41372-026-02693-y

Keywords:

Time-limited decision-making can funnel families into “either-or” pathways—consent is requested when options feel overwhelming, or it is deferred because the clinical situation is still evolving. That delay can unintentionally exclude eligible parents who may need time to process information, thereby skewing samples toward those with greater bandwidth.

Another challenge is consent complexity. Neonatal research involves high stakes, detailed protocols, and uncertainty that may persist for weeks. When researchers use process-heavy approaches—lengthy discussions, fragmented steps, or unclear timelines—families may interpret participation as a burden rather than an opportunity for contribution.

The quality improvement effort examined the neonatology research workflow from a family-centered perspective. Rather than treating enrollment as a purely administrative task, the team optimized the experience by redesigning how information is delivered and how support is coordinated across the clinical and research teams.

Technically, the project emphasized operational improvements that can be tracked over time—such as standardizing key steps, aligning messaging with family comprehension, and reducing friction between bedside care and research participation. These adjustments aim to make consent feel less like a one-time event and more like a guided process that fits the realities of neonatal care.

Importantly, the researchers argue that these procedural refinements can help counter selection bias. If enrollment barriers decrease, the likelihood increases that families who might otherwise decline—or be missed—are represented in study cohorts.

In viral science news, this shift matters beyond neonatology: it highlights a broader lesson for clinical research. Consent is not only a legal requirement; it is also a moment of communication design, shaped by time pressure, workload, and emotional context.

The work underscores that improving “how research feels” can improve “who research includes.” In neonatal settings, where the clock is unforgiving, careful workflow engineering may be as consequential as the science itself.

Subject of Research: Neonatology research enrollment, consent complexity, and selection bias reduction through quality improvement.

Article Title: A quality improvement project to optimize the neonatology research experience for families.

Article References: Castellanos, M.B., Baca-Arzaga, A., Mourão, M.L. et al. A quality improvement project to optimize the neonatology research experience for families. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02809-4

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41372-026-02809-4

Keywords:

The research focuses on analyzing the impact of PPC consultations on healthcare practices and resource use in NICUs where neonates are facing life-limiting conditions. PPC aims to provide holistic support—addressing physical symptoms, psychological burdens, and ethical complexities—yet its effect on concrete clinical practices in neonatal settings has remained understudied until now.

Methodologically, the study utilizes a retrospective design drawn from clinical data sets, comparing NICU care utilization metrics between cases that involved PPC consultations and those that did not. Metrics assessed include frequency and duration of invasive procedures, medication administration patterns, and lengths of NICU stays at end-of-life stages. This quantitative approach allows clear insights into how palliative consultation modifies clinical decision-making.

Results from the study definitively indicate a notable reduction in aggressive interventions and invasive treatments in neonates whose care included PPC consultation. There was also a trend toward earlier withdrawal of intensive life-sustaining measures, suggesting that integrating palliative expertise may facilitate a shift towards comfort-focused care, consistent with family preferences and ethical imperatives.

The findings provide compelling evidence that PPC consultation serves as a catalyst for aligning clinical interventions with quality-of-life considerations in neonatal care. By mitigating unnecessary and potentially burdensome treatments, PPC supports more humane, tailored care pathways for critically ill infants. This can potentially reduce medical futility and enhance parental satisfaction during profoundly difficult decision-making processes.

Experts believe that these results will encourage NICU teams to incorporate palliative care services more routinely, recognizing PPC not just as end-of-life support but an integral component of neonatal intensive care frameworks. The study emphasizes the importance of early, multidisciplinary collaboration between neonatologists, palliative specialists, and families.

This research also highlights broader implications for healthcare systems and policy makers seeking to optimize NICU resource utilization without compromising care quality or ethical standards. The demonstrated reduction in invasive care use may translate into decreased hospital costs alongside improved patient-centered outcomes.

As neonatal medicine continues to advance technologically, findings like these underscore that compassionate care strategies remain paramount. PPC consultation emerges as a vital practice to ensure that technological capabilities are applied judiciously, always prioritizing the best interests and dignity of vulnerable newborns.

In conclusion, this groundbreaking study illuminates the transformative potential of pediatric palliative care within NICUs. It paves the way for future prospective research into standardized PPC protocols and long-term outcomes for families navigating neonatal critical illness.

Subject of Research: Impact of pediatric palliative care consultation on neonatal end-of-life care utilization

Article Title: Impact of palliative care consultation on neonatal end-of-life care utilization

Article References:
Lin, M., Bosworth, O., Kazmi, S. et al. Impact of palliative care consultation on neonatal end-of-life care utilization. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02815-6

Image Credits: AI Generated

DOI: 14 July 2026

Patent ductus arteriosus, a congenital cardiac anomaly characterized by a persistent vascular connection between the aorta and pulmonary artery, is a significant contributor to morbidity in premature infants. The hemodynamic burden of PDA can exacerbate renal hypoperfusion, potentially leading to acute kidney injury (AKI) and chronic kidney disease in this sensitive patient group. Until now, the renal implications of minimally invasive transcatheter PDA closure remained incompletely understood, particularly in ELBW infants, whose tiny vessels and organ immaturity pose unique challenges.

The study evaluated renal function markers such as serum creatinine levels, estimated glomerular filtration rate (eGFR), and urine output before and after transcatheter PDA closure across several neonatal intensive care units. Crucially, the analysis distinguished infants with pre-existing renal insufficiency, allowing a nuanced understanding of how baseline renal status might modulate outcomes. Results revealed a generally favorable renal safety profile following the closure procedure. Kidney function remained stable or improved in most infants, indicating that eliminating the left-to-right shunting relieved renal ischemia caused by PDA-related low perfusion.

Interestingly, infants with pre-existing renal impairment demonstrated more variable trajectories post-closure, with some experiencing transient exacerbations of renal dysfunction. However, long-term follow-up suggested partial recovery and stabilization, underscoring that the procedure does not invariably exacerbate renal injury but requires vigilant perioperative management in this subset. The authors emphasize potential mechanisms including improved systemic circulation and reduced congestive effects on renal veins after PDA resolution, which may account for improved renal hemodynamics.

These findings have profound clinical implications, supporting the safety and utility of transcatheter PDA closure as a renal-sparing intervention in ELBW infants. The multicenter dataset strengthens the generalizability of these results and lays groundwork for standardized guidance on renal monitoring protocols tailored to high-risk neonates undergoing PDA closure. Further research is warranted to optimize timing and patient selection to maximize both cardiac and renal outcomes.

Experts praise the study for integrating cardiac and nephrology perspectives, an approach essential for managing the complex interorgan interactions in premature infants. As transcatheter techniques evolve and experience grows, understanding renal sequelae will inform holistic neonatal care strategies and improve survival with reduced morbidity. This research marks a significant advance, illuminating how cardiac interventions can harmonize with renal preservation in vulnerable newborns.

As neonatal intensive care embraces innovative therapies, scrutinizing systemic effects beyond immediate cardiac correction is paramount. This study exemplifies multidisciplinary efforts to decode the delicate balance between organ systems during critical developmental windows. In the future, such insights promise to refine protocols, improve quality of life, and reduce the burden of chronic kidney disease from the earliest stages of life.

Subject of Research: Renal function outcomes following transcatheter PDA closure in extremely low birth weight infants with and without pre-existing renal insufficiency.

Article Title: Impact of transcatheter PDA closure on renal function in extremely low birth weight infants—a multicenter study.

Article References: Herron, C., Ahluwalia, N., Fagan, T. et al. Impact of transcatheter PDA closure on renal function in extremely low birth weight infants—a multicenter study. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02820-9

DOI: 14 July 2026

Open maternal-fetal surgery typically occurs during the mid-trimester and involves opening the uterus to operate directly on the fetus. While surgeons aim to minimize risks, one rare but concerning complication is the emergent delivery of a fetus who is viable outside the womb. This scenario blurs the traditional boundaries between fetal surgery and neonatal resuscitation, raising questions about the clinical and moral responsibilities of care teams.

The authors argue that this narrow temporal and clinical zone demands precise ethical consideration. Unlike standard neonatal emergencies, the fetus in this scenario has undergone invasive prenatal intervention, making the stakes and complexity much higher. Determining the transition point where the perioperative care of the fetus ends and the full responsibilities of neonatal intensive care begin remains ambiguous and ethically significant.

A central challenge explored is how parental authority interacts with clinical judgement during this uncertain window. Parents typically wield significant discretion regarding in utero interventions, but emergent delivery transforms the fetus into a neonate capable of survival, thus altering the framework for decision-making. Medical teams must navigate this shift carefully, balancing respect for parental values with the infant’s best interests and evolving clinical imperatives.

The proposed ethical framework provides practical guidance to clinicians for anticipating and managing this intricate situation. It emphasizes clear communication with parents during pre-procedural counseling, outlining the potential for emergent delivery and explaining the implications for neonatal care. Such transparency can help prepare families for decision-making complexities should complications arise.

Furthermore, the framework underscores clinicians’ obligations to both the pregnant individual and the neonate. While fetal surgery offers no direct physiological benefit to the pregnant person, their health and autonomy remain paramount. Concurrently, any emergent neonate requires intensive resuscitation efforts and ethical consideration as a patient distinct from the fetus.

By delineating this perioperative-neonatal window, the article also advances ethical discourse in maternal-fetal medicine. It challenges existing paradigms of fetal patienthood, urging the medical community to refine protocols and training that reflect the unique realities of fetal surgery and emergent neonatal care.

Ultimately, as open fetal surgery expands with advancing technology, establishing robust ethical frameworks ensures just and compassionate care. This new analysis sets a foundation for clinical and ethical decision-making in unprecedented scenarios, reinforcing the need for ongoing dialogue at the intersection of prenatal and neonatal medicine.

Subject of Research: Ethical considerations in emergent delivery during open maternal-fetal surgery

Article Title: A proposed ethics framework for conceptualization of the perioperative-neonatal window in open fetal surgery

Article References:
Wolfe, I.D., Kamrath, H., Eyerly-Webb, S. et al. A proposed ethics framework for conceptualization of the perioperative-neonatal window in open fetal surgery. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02810-x

Image Credits: AI Generated

DOI: 14 July 2026

Preterm infants frequently require complex respiratory management due to underdeveloped lungs and associated complications. While escalation of care in quaternary NICUs can be lifesaving, clinicians have struggled to accurately predict which infants will face the gravest risks. The multidisciplinary team led by Sanabria, Dahash, and Natarajan sought to fill this gap by analyzing clinical variables associated with adverse respiratory outcomes.

Their study involved comprehensive evaluation of preterm infants referred for respiratory escalation, meticulously tracking patient data at or beyond the 34-week PMA threshold. Utilizing advanced statistical modeling, the investigators identified key predictors strongly correlated with death or the necessity of tracheostomy. These predictors provide clinicians with refined risk stratification tools, enhancing decision-making around treatment plans and family counseling.

One of the hallmarks of this research is its focus on a vulnerable population often neglected in outcome prediction studies: older preterm infants on the cusp of term-equivalent age but still requiring intensive respiratory support. By honing in on this specific developmental window, the team was able to discern subtle clinical signals that portend poor prognosis, thereby tailoring care pathways more precisely.

The methodology integrated detailed respiratory parameters, underlying medical conditions, and intervention histories to construct a robust predictive framework. Such precision medicine approaches hold promise not only for individual patient outcomes but also for optimizing utilization of NICU resources in highly specialized care environments.

Clinical implications are profound: early identification of infants at high risk for tracheostomy or mortality could prompt proactive therapeutic strategies and enable timely family discussions about long-term care planning. Moreover, this predictive capability may facilitate enrollment in clinical trials aimed at mitigating respiratory failure and improving survival.

This pioneering prognostic model marks a significant advance in neonatology, harnessing data-driven insights to confront the complex challenges of preterm infant respiratory care. Future studies expanding on this foundation could integrate biomarkers or genetic data, further enhancing prediction accuracy.

In essence, the work by Sanabria and colleagues equips neonatologists with crucial tools to navigate the intricate clinical landscape faced by preterm infants transitioning through vulnerable stages of lung development. As NICUs continue to evolve with technological and medical advancements, such evidence-based predictive frameworks will be instrumental in improving neonatal survival and quality of life.

Subject of Research: Prediction of outcomes in preterm infants referred for respiratory escalation at ≥34 weeks PMA

Article Title: Prediction of outcomes for premature infants referred to a quaternary NICU for respiratory escalation

Article References:
Sanabria, D., Dahash, B. & Natarajan, G. Prediction of outcomes for premature infants referred to a quaternary NICU for respiratory escalation. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02801-y

Image Credits: AI Generated

DOI: 10.1038/s41372-026-02801-y

Necrotizing enterocolitis is a devastating gastrointestinal disease primarily affecting premature infants, marked by inflammation and bacterial invasion of the intestinal wall, which can lead to bowel necrosis. Given the condition’s high morbidity and mortality rates, probiotic therapies—live microorganisms that confer health benefits when administered in adequate amounts—have been extensively explored as a preventative strategy. Probiotics are believed to promote gut colonization by beneficial bacteria, enhance mucosal barrier function, and modulate immune responses in the immature intestinal environment.

However, in recent years, the FDA issued warnings regarding the use of probiotics in vulnerable populations after reports of contamination and inconsistent product quality. These cautions led to a decline in probiotic usage in neonatal intensive care units across the United States, despite accumulating evidence from randomized controlled trials supporting their protective effect against NEC. The published correction addresses discrepancies and updates data interpretations in prior analyses to clarify probiotic safety under the shadow of regulatory concerns.

The authors emphasize that the contamination events, while serious, represent isolated manufacturing lapses rather than inherent risks of probiotics themselves. They underscore the importance of stringent quality control and standardized production processes to ensure the microbial strains administered are viable, pure, and clinically appropriate. Their analysis also suggests that, when produced and monitored properly, probiotics retain a favorable risk-benefit profile for preterm infants at risk of NEC.

Technically, the corrected data refine the understanding of probiotic strain-specific outcomes, dosing parameters, and timing of administration. For instance, multi-strain formulations containing Bifidobacterium and Lactobacillus species demonstrate more pronounced protective effects compared to single-strain products. Timing appears critical as well; early initiation within the first few days of life aligns with optimal colonization and immune priming. Such details hold paramount clinical relevance given the fragile physiology of these neonates and the rapid progression of NEC.

The broader clinical implications of this correction are significant. Neonatologists and healthcare providers are compelled to carefully evaluate the evidence base, balancing regulatory guidance with emerging research. It reinvigorates calls for rigorous, well-designed trials to confirm probiotic safety and effectiveness, alongside regulatory pathways that accommodate the unique challenges of probiotic therapeutics.

In summary, this correction serves as a pivotal update in the evolving landscape of neonatal care, bringing clarity to an area once overshadowed by cautionary regulatory actions. It reiterates that, with proper oversight and a precision-medicine approach, probiotics remain a promising tool in preventing one of the most feared complications of prematurity. The neonatal field now awaits further translational and clinical research to solidify these insights and translate them into standardized therapeutic protocols.

Subject of Research: Probiotics and Necrotizing Enterocolitis in Preterm Infants

Article Title: Correction: Probiotics and necrotizing enterocolitis in preterm infants after the food and drug administration warning actions

Article References:
Tolia, V.N., Bennett, M.M., Handler, D. et al. Correction: Probiotics and necrotizing enterocolitis in preterm infants after the food and drug administration warning actions. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02802-x

Image Credits: AI Generated

Vitamin K plays a crucial role in blood coagulation, and its deficiency in newborns can lead to Vitamin K Deficiency Bleeding (VKDB), which, without prophylaxis, can cause severe hemorrhagic events in neonates. Since many newborns have low vitamin K stores at birth, medical guidelines worldwide recommend routine administration of vitamin K shortly after delivery. However, this new investigation reveals significant gaps in adherence to these protocols.

The study analyzed health records from a vast network, reviewing the incidence of documented vitamin K administration in the newborn population. Findings disclosed that a considerable proportion of infants lacked recorded evidence of receiving this lifesaving intervention. This shortfall was not uniformly distributed but was influenced by various clinical and demographic factors, suggesting that both systemic healthcare variables and parental decision-making might play roles.

Importantly, the analysis extended beyond identifying these documentation lapses to correlate them with clinical outcomes. Neonates without documented vitamin K prophylaxis exhibited a higher incidence of bleeding complications, underscoring the real-world implications of these procedural omissions. This connection establishes a critical link between paperwork, practice, and patient well-being.

The research delved into predictors for the absence of documented vitamin K administration, highlighting potential socioeconomic disparities, variations in hospital policies, and parental hesitancy or refusal as possible contributors. This multi-layered causality suggests that addressing the issue will require comprehensive strategies involving education, policy reinforcement, and community engagement.

From a technical perspective, the study utilized advanced statistical modeling to parse out the influence of confounding variables, thus strengthening the validity of its findings. The precise quantification of bleeding risk attributable to non-administration provides a compelling argument for stringent adherence to vitamin K prophylactic protocols.

These revelations arrive at a pivotal juncture, as growing skepticism toward routine neonatal interventions has gained traction in certain communities. This research serves as an empirical counterweight, reaffirming the undeniable benefits and necessity of vitamin K administration shortly after birth.

Healthcare systems and providers are now equipped with data-driven evidence that underscores the critical nature of documentation and administration of vitamin K prophylaxis. The study advocates for enhanced training, improved electronic health record systems, and parental counseling as key measures to eradicate documentation lapses and protect newborn health.

In summary, this investigation furnishes a vital reminder that preventive neonatal care protocols, especially the administration of vitamin K, must not only be followed but meticulously documented to safeguard infants from preventable hemorrhagic complications. The findings invite a renewed commitment across healthcare networks to close the gaps in this essential practice.

Subject of Research: Prophylactic vitamin K administration in newborns and its impact on bleeding outcomes

Article Title: Lack of documented prophylactic vitamin K administration in newborns: incidence, predictors, and bleeding outcomes in a large healthcare network population

Article References:
Bloom, B.T., Keller, M.A., Ahmad, K.A. et al. Lack of documented prophylactic vitamin K administration in newborns: incidence, predictors, and bleeding outcomes in a large healthcare network population. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02797-5

Image Credits: AI Generated

DOI: 10 July 2026